This 2016 metaanalysis combines 355 patients with locally advanced pancreatic cancer and the median overall survival of the pooled data was found to be 24·2 months. The confidence interval computed around this estimate tells us that can be 95% certain that the true average OS of the population lies between 21.7 and 26.8 months (95% CI 21·7-26·8). So OS of 16 months is not impressive.
CC
Article here https://www.ncbi.nlm.nih.gov/pubmed/27160474
- Forums
- ASX - By Stock
- Ann: Positive Overall Survival data released at ASCO 2019 Chicago
This 2016 metaanalysis combines 355 patients with locally...
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.99M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $1.536K | 256K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2871929 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 19743778 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2871929 | 0.005 |
30 | 23116698 | 0.004 |
11 | 11443298 | 0.003 |
6 | 5457516 | 0.002 |
4 | 7800000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 19743778 | 22 |
0.007 | 24904167 | 20 |
0.008 | 9543848 | 10 |
0.009 | 12462253 | 5 |
0.010 | 6693666 | 5 |
Last trade - 10.06am 03/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online